COVID VACCINE INVESTING. Up to date information about the smaller bio-pharmaceutical companies developing a COVID vaccine. This blog features a COVID INVESTOR INDEX which keeps track of the relative performance of 28 key COVID VACCINE companies.
Thursday 25 February 2021
Selling lets up - GeoVax gains over 11%
Selling stops and we get a modest bounce back lead by GeoVax, climbing over 11%. 18 stocks managed gains with eight falling and one flat.
Vaxart climbed 8%, while Emergent and Generex gained over 5%.
No comments:
Post a Comment